Skip to main content
Give
Division of Nephrology
DepartmentsDepartment of MedicineDivisionsDivision of NephrologyPublications2015 Divisional Bibliography

2015 Divisional Bibliography

Peer Reviewed

  1. Anderson AH, Yang W, Townsend RR, Pan Q, Chertow GM, Kusek JW, Charleston J, He J, Kallem R, Lash JP, Miller ER 3rd, Rahman M, Steigerwalt S, Weir M, Wright JT Jr, Feldman HI; Chronic Renal Insufficiency Cohort Study Investigators. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med. 2015 Feb 17;162(4):258-65.
  2. Armando I, Villar VA, Jose PA. Genomics and Pharmacogenomics of Salt-sensitive Hypertension. Curr Hypertens Rev. 2015;11(1):49-56.
  3. Bahrainwala J, Patel A, Diaz KM, Veerabhadrappa P, Cohen DL, Cucchiara A, Townsend RR. Ambulatory Arterial Stiffness Index and Circadian Blood Pressure Variability J Am Soc Hypertens 2015; 9(9): 705-10.
  4. Bakris GL, Pitt B, Weir MR, Freeman MW, Mayo MR, Garza D, Stasiv Y, Zawadzki R, Berman L, Bushinsky DA; AMETHYST-DN Investigators. Effect of Patiromer on Serum Potassium Level in Patients with Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial. J Am Med Assoc. 2015 July 14;314(2):151-61.
  5. Bushinsky DA, Williams GH, Pitt B, Weir MR, Freeman MW, Garza D, Stasiv Y, Li E, Berman L, Bakris GL. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015 Dec; 88(6):1427-1433.
  6. Cai J, Guan W, Tan X, Chen C, Li L, Wang N, Zou X, Zhou F, Wang J, Pei F, Chen X, Luo H, Wang X, He D, Zhou L, Jose PA, Zeng C. SRY gene transferred by extracellular vesicles accelerates atherosclerosis by promotion of leucocyte adherence to endothelial cells. Clin Sci (Lond). 2015 Aug;129(3):259-69.
  7. Campbell D, Weir MR. Defining, Treating, and Understanding Chronic Kidney Disease – A Complex Disorder. J Clin Hypertens (Greenwich). 2015 Jul;17(7):514-27.
  8. Chen K, Deng K, Wang X, Wang Z, Zheng S, Ren H, He D, Han Y, Asico LD, Jose PA, Zeng C. Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Hypertension. 2015 Jan;65(1):153-60.
  9. Cohen EP, Fish BL, Moulder JE. Late-onset effects of radiation and chronic kidney disease. Lancet. 2015 Oct 31;386(10005):1737-8.
  10. Cohen EP, Krzesinski JM, Launay-Vacher V, Sprangers B. Onco-Nephrology: Core Curriculum 2015. Am J Kidney Dis. 2015 Nov;66(5):869-83.
  11. Croft LD, Liquori M, Ladd J, Day H, Pineles L, Lamos E, Arnold R, Mehrotra P, Fink JC, Langenberg P, Simoni-Wastila L, Perencevich E, Harris AD, Morgan DJ. The Effect of Contact Precautions on Frequency of Hospital Adverse Events. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1268-74.
  12. Croft LD, Harris AD, Pineles L, Langenberg P, Shardell M, Fink JC, Simoni-Wastila L, Morgan DJ; Benefits of Universal Glove and Gown Primary Investigators. The Effect of Universal Glove and Gown Use on Adverse Events in Intensive Care Unit Patients. Clin Infect Dis. 2015 Aug 15;61(4):545-53.
  13. Cuevas S, Yang Y, Konkalmatt P, Asico LD, Feranil J, Jones J, Villar VA, Armando I, Jose PA. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1. Hypertension. 2015 Jun;65(6):1251-7.
  14. deFilippi CR, Seliger SL. Natriuretic peptide and cardiovascular risk: is it about "U"? J Am Heart Assoc. 2015 May 21;4(5).
  15. Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2073-83.
  16. Dhakal B, Singavi A, Cohen EP, Dangal M, Palmer J, Dall A, D'Souza A, Hamadani M, Hari PN. Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes. Bone Marrow Transplant. 2015 Mar;50(3):449-51.
  17. Diamantidis CJ, Ginsberg JS, Yoffe M, Lucas L, Prakash D, Aggarwal S, Fink W, Becker S, Fink JC. Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD. Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1364-70.
  18. Elias MF, Seliger SL, Torres RV. Improved cognitive performance after a single dialysis session: where do we go from here? Nephrol Dial Transplant. 2015 Sep;30(9):1414-7.
  19. Gildea JJ, Xu P, Carlson JM, Gaglione RT, Bigler Wang D, Kemp BA, Reyes CM, McGrath HE, Carey RM, Jose PA, Felder RA.The sodium-bicarbonate cotransporter NBCe2 (slc4a5) expressed in human renal proximal tubules shows increased apical expression under high-salt conditions. Am J Physiol Regul Integr Comp Physiol. 2015 Dec 1;309(11):R1447-59. doi: 10.1152/ajpregu.00150.2015.
  20. Gill K, Fink JC, Gilbertson DT, Monda KL, Muntner P, Lafayette RA, Petersen J, Chertow GM, Bradbury BD. Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease. Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):654-62.
  21. Gorski M, Tin A, Garnaas M, McMahon GM, Chu AY, Tayo BO, Pattaro C, Teumer A, Chasman DI, Chalmers J, Hamet P, Tremblay J, Woodward M, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Smith AV, Mitchell BD, O'Connell JR, Shuldiner AR, Coresh J, Li M, Freudenberger P, Hofer E, Schmidt H, Schmidt R, Holliday EG, Mitchell P, Wang JJ, de Boer IH, Li G, Siscovick DS, Kutalik Z, Corre T, Vollenweider P, Waeber G, Gupta J, Kanetsky PA, Hwang SJ, Olden M, Yang Q, de Andrade M, Atkinson EJ, Kardia SL, Turner ST, Stafford JM, Ding J, Liu Y, Barlassina C, Cusi D, Salvi E, Staessen JA, Ridker PM, Grallert H, Meisinger C, Müller-Nurasyid M, Krämer BK, Kramer H, Rosas SE, Nolte IM, Penninx BW, Snieder H, Fabiola Del Greco M, Franke A, Nöthlings U, Lieb W, Bakker SJ, Gansevoort RT, van der Harst P, Dehghan A, Franco OH, Hofman A, Rivadeneira F, Sedaghat S, Uitterlinden AG, Coassin S, Haun M, Kollerits B, Kronenberg F, Paulweber B, Aumann N, Endlich K, Pietzner M, Völker U, Rettig R, Chouraki V, Helmer C, Lambert JC, Metzger M, Stengel B, Lehtimäki T, Lyytikäinen LP, Raitakari O, Johnson A, Parsa A, Bochud M, Heid IM, Goessling W, Köttgen A, Kao WH, Fox CS, Böger CA. Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int. 2015 May;87(5):1017-29.
  22. Grunwald JE, Pistilli M, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker-Ostroff C, Mohler E, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D; CRIC Study Investigators. Retinopathy and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2015 Nov 15;116(10):1527-33.
  23. Gupta J, Dominic EA, Fink JC, Ojo AO, Barrows IR, Reilly MP, Townsend RR, Joffe MM, Rosas SE, Wolman M, Patel SS, Keane MG, Feldman HI, Kusek JW, Raj DS; CRIC Study Investigators. Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2015 Apr 24;10(4):e0124772.
  24. Han F, Konkalmatt P, Chen J, Gildea J, Felder RA, Jose PA, Armando I. MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension. 2015 May;65(5):1118-25.
  25. Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int. 2015 Mar;87(3):527-534.
  26. Hart A, Weir MR, Kasiske BL. The authors reply. Kidney Int. 2015 Apr;87(4):863-4.
  27. Hsu KL, Fink JC, Ginsberg JS, Yoffe M, Zhan M, Fink W, Woods CM, Diamantidis CJ. Self-reported Medication Adherence and Adverse Patient Safety Events in CKD. Am J Kidney Dis. 2015 Oct;66(4):621-9.
  28. Jose PA, Raj D. Gut microbiota in hypertension. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):403-9.
  29. Kasiske BL, Anderson-Haag T, Israni AK, Kalil RS, Kimmel PL, Kraus ES, Kumar R, Posselt AA, Pesavento TE, Rabb H, Steffes MW, Snyder JJ, Weir MR. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis. 2015 Jul;66(1):114-24.
  30. Launay-Vacher V, Aapro M, De Castro G Jr, Cohen E, Deray G, Dooley M, Humphreys B, Lichtman S, Rey J, Scotté F, Wildiers H, Sprangers B. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN). Ann Oncol. 2015 Aug;26(8):1677-84.
  31. Li F, Yang J, Jones JE, Villar VA, Yu P, Armando I, Felder RA, Jose PA. Sorting nexin 5 and dopamine D1 receptor regulate the expression of the insulin receptor in human renal proximal tubule cells. Endocrinology. 2015 Jun;156(6):2211-21.
  32. Lin J, Zhang X, Xue C, Zhang H, Shashaty MG, Gosai SJ, Meyer N, Grazioli A, Hinkle C, Caughey J, Li W, Susztak K, Gregory BD, Li M, Reilly MP. The long noncoding RNA landscape in hypoxic and inflammatory renal epithelial injury. Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F901-13.
  33. Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, He J, Kallem RR, Kusek JW, Master SR, Miller ER 3rd, Rosas SE, Steigerwalt S, Tao K, Weir MR, Hsu CY; CRIC Study Investigators. Urine Neutrophil Gelatinase-Associated Lipocalin and Risk of Cardiovascular Disease and Death in CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Feb;65(2):267-74.
  34. Liu X, Wang W, Chen W, Jiang X, Zhang Y, Wang Z, Yang J, Jones JE, Jose PA, Yang Z. Regulation of blood pressure, oxidative stress and AT1R by high salt diet in mutant human dopamine D5 receptor transgenic mice. Hypertens Res. 2015 Jun;38(6):394-9.
  35. Mindikoglu AL, Dowling TC, Schaub DJ, Hutson WR, Potosky DR, Christenson RH, Barth RN, LaMattina JC, Hanish SI, Weir MR, Raufman JP. Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. Dig Dis Sci. 2015 Nov;60(11):3491-4.
  36. Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. Clin Chem. 2015 Dec;61(12):1524-31.
  37. Parikh RH, Seliger SL, deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015 Mar;48(4-5):247-53.
  38. Pitt B, Bakris GL, Bushinsky DA, Garza D, Mayo MR, Stasiv Y, Christ-Schmidt H, Berman L, Weir MR. Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors. Eur J Heart Fail. 2015 Oct;17(10):1057-65.
  39. Qiu B, Ackerman D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, Bobrovnikova-Marjon E, Diehl JA, Keith B, Simon MC. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 2015 Jun;5(6):652-67
  40. Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, Dember LM, Fink JC, Frydrych A, Jensvold NG, Lustigova E, Nessel LC, Porter AC, Rahman M, Wright Nunes JA, Daviglus ML, Lash JP; CRIC Study Investigators. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Mar;65(3):412-24.
  41. Romero CA, Orias M, Weir MR. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol. 2015 Apr;11(4):242-252.
  42. Rubin MF, Weir MR. Access to Kidney Transplantation: Is There a Potential Conflict of Interest? Am J Nephrol. 2015;41(6):502-3.
  43. Rudemiller NP, Lund H, Priestley JR, Endres BT, Prokop JW, Jacob HJ, Geurts AM, Cohen EP, Mattson DL. Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation. Hypertension. 2015 May;65(5):1111-7.
  44. Sandsmark DK, Messé SR, Zhang X, Roy J, Nessel L, Lee Hamm L, He J, Horwitz EJ, Jaar BG, Kallem RR, Kusek JW, Mohler ER 3rd, Porter A, Seliger SL, Sozio SM, Townsend RR, Feldman HI, Kasner SE; CRIC Study Investigators. Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study. Stroke. 2015 Aug;46(8):2075-80.
  45. Seliger SL, de Lemos J, Neeland IJ, Christenson R, Gottdiener J, Drazner MH, Berry J, Sorkin J, deFilippi C. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). JACC Heart Fail. 2015 Jun;3(6):445-55.
  46. Seliger SL. Frailty and Cognitive Impairment in ESRD: Brain-Body Connections. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2104-6.
  47. Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB. Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol. 2015;41(4-5):305-12.
  48. Thomas B, Weir MR. The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient. Curr Cardiol Rep. 2015 Nov;17(11):95.
  49. Unthank JL, Miller SJ, Quickery AK, Ferguson EL, Wang M, Sampson CH, Chua HL, DiStasi MR, Feng H, Fisher A, Katz BP, Plett PA, Sandusky GE, Sellamuthu R, Vemula S, Cohen EP, MacVittie TJ, Orschell CM. Delayed Effects of Acute Radiation Exposure in a Murine Model of the H-ARS: Multiple-Organ Injury Consequent to <10 Gy Total Body Irradiation. Health Phys. 2015 Nov;109(5):511-21.
  50. Wagner LA, Tata AL, Fink JC. Patient safety issues in CKD: core curriculum 2015. Am J Kidney Dis. 2015 Jul;66(1):159-69.
  51. Wang C, Luo Z, Kohan D, Wellstein A, Jose PA, Welch WJ, Wilcox CS, Wang D. Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease. Hypertension. 2015 May;65(5):1055-63
  52. Wang Z, Guan W, Han Y, Ren H, Tang X, Zhang H, Liu Y, Fu J, He D, Asico LD, Jose PA, Zhou L, Chen L, Zeng C. Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12. Transplantation. 2015 Nov;99(11):2274-84.
  53. Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv, Wittes J, Christ-Schmidt H, Berman L, Pitt B; the OPAL-HK Investigators. Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors. N Engl J Med. 2015 Jan 15;372(3):211-21.
  54. Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A, Mitsnefes MM, Sica DA, Taler SJ. Assessment and Management of Hypertension in Transplant Patients. J Am Soc Nephrol. 2015;26:1248-1260.
  55. Weir MR. Is There an Optimal Strategy for Pretransplant Cardiovascular Screening? Transplantation. 2015 April;99(4):656-7.
  56. Weir MR, Bakris GL, Pit B. New agents for hyperkalemia. N Engl J Med. 2015 Apr 16; 372(16):1570-1.
  57. Weir MR, Espaillat R. Clinical perspectives on the rationale for potassium supplementation. Postgrad Med. 2015 Jun; 127(5):539-48.
  58. Weir MR. CCR2 inhibition: a panacea for diabetic kidney disease? Lancet Diabetes Endocrinol. 2015 Sep; 3(9):663-7.
  59. Weir MR. Diabetic nephropathy: Nonsteroidal MRA added to RAS blockade reduces albuminuria. Nat Rev Nephrol. 2015 Dec; 11(12):691-2.
  60. Wu J, Ginsberg JS, Zhan M, Diamantidis CJ, Chen J, Woods C, Fink JC. Chronic pain and analgesic use in CKD: implications for patient safety. Clin J Am Soc Nephrol. 2015 Mar 6;10(3):435-42.
  61. Yang J, Villar VA, Jones JE, Jose PA, Zeng C. G protein-coupled receptor kinase 4: role in hypertension. Hypertension. 2015 Jun;65(6):1148-55.
  62. Yang Y, Cai Y, Wu G, Chen X, Liu Y, Wang X, Yu J, Li C, Chen X, Jose PA, Zhou L, Zeng C.Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci (Lond). 2015 Oct 1;129(8):675-85.
  63. Yang S, Han Y, Zheng S, Kou X, Asico LD, Huang H, Gao Z, Jose PA, Zeng C. enhanced natriuresis and diuresis in Wistar rats caused by the costimulation of renal dopamine D3 and angiotensin ii type 2 receptors. Am J Hypertens. 2015 Oct;28(10):1267-76.
  64. Yang S, Yang Y, Yu P, Yang J, Jiang X, Villar VA, Sibley DR, Jose PA, Zeng C. Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells. Free Radic Res. 2015 Apr;49(4):397-410.
  65. Yu C, Chen J, Guan W, Han Y, Wang WE, Wang X, Wang H, Jose PA, Zeng C . Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression. Hypertens Res. 2015 Sep;38 (9):588-96.

Book Chapters

  1. Karadsheh F. Weir MR.  Hematologic Complications of Chronic Kidney Disease: Leukocyte and Monocyte Function. In: P. Kimmel & M. Rosenberg, eds. Chronic Renal Disease. Oxford: Elsevier; 2015: 277-284.
  2. Krzesinski JM, Cohen EP. Approach to the patient with oedema in Oxford Textbook of Clinical Nephrology, 4th Ed Turner N et al, editors.